Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-2001 | 02-2000 | 02-1999 | 02-1998 | 02-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 46,100 | 46,160 | 58,700 | 56,410 | 44,040 |
| Depreciation Amortization | 22,960 | 17,070 | 12,550 | 10,460 | 6,272 |
| Other Working Capital | 9,970 | -930 | -9,630 | -13,260 | -9,797 |
| Other Operating Activity | -1,020 | 380 | -990 | 1,940 | -1,062 |
| Operating Cash Flow | $78,010 | $62,680 | $60,630 | $55,550 | $39,453 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -41,710 | -33,280 | -20,220 | -22,850 | -17,654 |
| Net Acquisitions | 0 | 0 | -1,650 | -2,830 | 0 |
| Other Investing Activity | -200 | 20,830 | -2,930 | -52,650 | 4,283 |
| Investing Cash Flow | $-41,910 | $-12,450 | $-24,800 | $-78,330 | $-13,371 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -26,570 | -38,590 | -54,940 | -14,490 | -15,242 |
| Financing Cash Flow | $-26,570 | $-38,590 | $-54,940 | $-14,490 | $-15,242 |
| Beginning Cash Position | 27,140 | 15,490 | 34,610 | 71,880 | 61,047 |
| End Cash Position | 36,670 | 27,140 | 15,490 | 34,610 | 71,887 |
| Net Cash Flow | $9,530 | $11,640 | $-19,110 | $-37,270 | $10,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | 78,010 | 62,680 | 60,630 | 55,550 | 39,453 |
| Free Cash Flow | 78,010 | 62,680 | 60,630 | 55,550 | 39,453 |